Akoya Biosciences, Inc.
AKYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $12 | $13 | $9 |
| Short-Term Investments | $7 | $23 | $23 | $36 |
| Receivables | $12 | $14 | $13 | $17 |
| Inventory | $23 | $24 | $25 | $25 |
| Other Curr. Assets | $4 | $4 | $3 | $3 |
| Total Curr. Assets | $66 | $77 | $77 | $90 |
| Property Plant & Equip (Net) | $12 | $13 | $14 | $14 |
| Goodwill | $18 | $18 | $18 | $18 |
| Intangibles | $14 | $15 | $15 | $16 |
| Long-Term Investments | $0 | $0 | $3 | $3 |
| Tax Assets | $0 | $0 | $0 | -$4 |
| Other NC Assets | $2 | $2 | $2 | $6 |
| Total NC Assets | $46 | $48 | $53 | $54 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $113 | $125 | $130 | $144 |
| Liabilities | – | – | – | – |
| Payables | $10 | $9 | $9 | $10 |
| Short-Term Debt | $76 | $3 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $8 | $7 | $7 | $6 |
| Other Curr. Liab. | $2 | $3 | -$2 | $5 |
| Total Curr. Liab. | $108 | $29 | $28 | $33 |
| LT Debt | $0 | $76 | $76 | $76 |
| Deferred Rev, NC | $3 | $3 | $3 | $3 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $4 | $4 | $4 |
| Total NC Liab. | $10 | $88 | $88 | $89 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $8 | $9 | $9 |
| Total Liabilities | $119 | $117 | $116 | $121 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$301 | -$285 | -$277 | -$267 |
| AOCI | -$0 | $0 | $0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$6 | $8 | $14 | $22 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $113 | $125 | $130 | $144 |
| Net Debt | $56 | $68 | $67 | $70 |